Today is: April 17, 2011

Evaluate Your Case Today







Calcagno & Associates

900 South Avenue, 3rd Floor
Staten Island, NY, 10314
Phone: 1-800-WE-FIGHT
             (718) 568-3585


By appointment only

Battery Place
New York, NY, 10004
Phone: (800) 933-4448

Grand Concourse Bronx, NY, 10451 Phone: (718) 933-4448

Bay Parkway Brooklyn, NY, 11214 Phone: (800) 487-6837


Name (First & Last)
DOB (Victims Date of Birth)

Phone

Email Address

Address

City

State

ZipCode

Message about your case

Viagra

Viagra impotence pill was FDA approved in March 1998 as the first oral pill to treat the male dysfunction affecting millions of men in the U.S. In May 1998, Pfizer issued a “Dear Doctor” letter warning of the large and sudden drops in systemic blood pressure occurring in the majority of patients taking Viagra. Doctors were advised to consider the cardiac status of patients that were being prescribed Viagra.

In November 1998, the FDA and Pfizer advised doctors that Viagra labeling would contain new warnings and information in the product labeling for Viagra in response to postmarketing reports of serious adverse events. The new Viagra labeling warned of cardiac effects, such as heart attacks, sudden cardiac deaths, and hypertension that had occurred in Viagra patients. In addition, men were reporting instances of priapism, or painful, prolonged erections, a serious condition requiring immediate medical attention.

Contact us for more information on Viagra.

Return to Defective Drugs Listing

 

Keywords | Articles | Locations | Coupons |